InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Kollender Richard S, Chief Financial Officer. Director active across 3 companies, notably Strongbridge Biopharma plc. Aggregated, 12 filings have been published. The latest transaction was filed on 1 October 2021 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
234,229 shares
Ordinary Shares
SEC:0001179110-21-009284·
234,229 shares
Ordinary Shares
SEC:0001179110-21-009284:0·
€115,31464,791 shares@ €1.779868.3% of flow
Ordinary Shares
SEC:0001179110-21-009228·
€115,31464,791 shares@ €1.779868.3% of flow
Ordinary Shares
SEC:0001179110-21-009228:0·
€4,558107,816 shares@ €0.0423100.0% of flow
Class A Common Stock
SEC:0001104659-21-115207·
€4,558107,816 shares@ €0.04230.0048% mcap50.0% of flow
Class A Common Stock
SEC:0001104659-21-115207:0·
€32,22917,088 shares@ €1.886119.1% of flow
Ordinary Shares
SEC:0001179110-21-008673·
€32,22917,088 shares@ €1.886119.1% of flow
Ordinary Shares
SEC:0001179110-21-008673:0·
1,315,084 shares
Class A Common Stock
SEC:0001104659-21-094111·
1,315,084 shares
Class A Common Stock
SEC:0001104659-21-094111:0·
€21,36511,392 shares@ €1.875512.6% of flow
Ordinary Shares
SEC:0001179110-21-005554·
€21,36511,392 shares@ €1.875512.6% of flow
Ordinary Shares
SEC:0001179110-21-005554:0·
12 of 12 declarations
About Kollender Richard S
Richard S. Kollender is President and CFO of Strongbridge Biopharma plc and RAPID MICRO BIOSYSTEMS, INC. In these roles, he is responsible for financial management and strategic leadership of both companies. Richard plays a key role in developing financial strategies that support growth and profitability.
